Polyoxazolines

Polyoxazolines are a class of biopolymers formed from oxazolines, which are 5 membered rings containing nitrogen and oxygen. These polymers can be utilized in a variety of potential biomedical applications, such as drug conjugation for targeted drug delivery and other nanomaterials. Research has noted their particularly stealthy nature, which is defined as a lack of an immunogenic response when utilized in vivo.

Overview of biopolymers

Natural and synthetic polymers, such as cellulose, collagen, biodegradable poly(ethylene glycol) (PEG), and others have widely been used in biomedical engineering. A popular biopolymer choice is PEG,  and the conjugation of biopharmaceuticals to PEG is a process called PEGylation which has led to a number of important macromolecule drugs through modulation of their therapeutic properties. An alternative to PEG for use in biopolymers is Poly(2-oxazoline), or POx, which possesses an R group which can be modified unlike PEG. A similar alternative is Poly(6-oxazine), which utilizes 6 membered rings instead of 5 membered rings, which also can be utilized for biomedical applications.

History and development

Oxazolines are a type of cyclic imino ethers that comprise a five-membered ring. For the synthesis of POx, a living cationic ring-opening polymerization method (CROP) is utilized. This CROP synthesis was first discovered in 1956, when Swarc reported the first living polymerization, in which the termination of the polymer chain is controlled, opening up the field of living polymerizations. In 1966 and 1967, four different research groups reported the first utilization of this CROP synthesis for synthesizing POx specifically. In 1966, POx was introduced as an FDA approved food additive, due to its nontoxicity.

Synthesis

In this synthesis (Figure 2) 2-oxazoline attacks an initiator functionalized with a counter anion, X, to create a cationic intermediate after the initiation step. This intermediate is then attacked by another 2-oxazoline in the propagation step. Finally, the polymerization ends in the termination step with attack on the cationic 2-oxazoline with a terminator. Change of the initiator can implement a variety of different functional groups into the polymer. The common types of initiators include methyl 4-nitro(methyl)benzenesulfonate, methyl trifluoromethanesulfonate, chloroformate, acid halide, and brominated hydrocarbon. The terminator can also be used to implement various functionalities, and since this is added at the end of the synthesis, this can be utilized to introduce CROP incompatible groups into the polymer through their side chains. Many different terminators are commonly utilized, such as hydroxyl or amino, which can attenuate solubility or later be utilized in conjugation. Furthermore, the living nature of the polymerization enables control over areas such as molecular weight and molar mass distribution.

Generic overview of the CROP synthesis

General properties

POx have a wide range of physical properties which are applicable for biomedical uses. POx are stable at high temperatures, enabling broad temperature range usability.  Additionally, their tertiary amide-bearing backbone provides enhanced stability against oxidative degradation. POx can be also modulated with a variety of hydrophilic and hydrophobic monomers to attenuate solubility. Different POx can be attenuated to possess different lower critical solution temperatures (LCST), contributing to their solubility and miscibility in a variety of organic solvents and aqueous solutions. In addition, some POx can possess strong thermo-responsivity, enabling use of POx in cell sheet engineering.

Varying hydrophobicity of different POx molecules and comparison to polypeptides

POx has differentiated itself from the popular choice of PEG for use in biopolymers. Anti-PEG antibodies have been observed in a significant number of patients, including 25% of patients never treated with PEG drugs, possibly due to its ubiquity in cosmetics and food additives. This immunogenic response could contribute to accelerated blood clearance after multiple injections. POx has found attention in this regard; it does not illicit an immunogenic response. POx exhibit a peptidomimetic structure composed of a tertiary amide backbone, but unlike natural polypeptides, POx cannot be degraded by proteases. In addition to its biocompatibility, POx has been shown to exhibit higher stability and tunability than PEG with the presence of its third functional R group handle. Furthermore, POx can be utilized for the fabrication of antifouling coatings, which can be resistant to physiological conditions for longer periods with respect to their PEG analogues. For solubility, POx can be tuned to be more hydrophilic than PEG, which can help in therapeutics and drug delivery.

Utilization

Example of Micelle for Hydrophobic Compound Delivery using POx Polymers

POx can be utilized in a variety of nanomaterials. POx can be used for the creation of biocompatible surfactants. POx can also be utilized in micelles for the facilitation of hydrophobic compound delivery in aqueous solutions (Figure 4). Research has reported that POx can possess self assembly properties and can form micelles. A different utilization for POx is in hydrogels, which can form spherical nanogels in aqueous solutions for drug delivery. These three-dimensional structures, formed through crosslinking polymers, provide an opportunity to model the complex and transformable environment of the extra cellular membrane. Furthermore, these POx hydrogels can be used to created water-stable scaffolds. For other nanomaterial uses, POx can be used in functionalized nanoparticles with a variety of materials, such as Au. These nanoparticles can be utilized for targeted drug delivery. POx can be used in microgels, which can be useful for neuronal cell culture.

Example of POx Protein/Drug Conjugates Functionalized with Imaging Material for in vivo imaging

POx can be used in covalent protein/drug conjugates. Similarly to how PEG can be covalently linked with proteins for targeted drug delivery, POx can be utilized for the same purpose. In addition, imaging material can be conjugated for use in in vivo imaging. These functionalizations can be facilitated through POx’s well documented compatibility with Copper Catalyzed Click reactions. Overall, this strategy has showcased promising initial results for use in cancer detection.

References

  1. 1 2 3 4 5 6 7 8 Glassner, Mathias; Vergaelen, Maarten; Hoogenboom, Richard (January 2018). "Poly(2-oxazoline)s: A comprehensive overview of polymer structures and their physical properties". Polymer International. 67 (1): 32–45. doi:10.1002/pi.5457. ISSN 0959-8103.
  2. 1 2 Wloka, Thomas; Czich, Steffen; Kleinsteuber, Maximilian; Moek, Elisabeth; Weber, Christine; Gottschaldt, Michael; Liefeith, Klaus; Schubert, Ulrich S. (January 2020). "Microfabrication of 3D-hydrogels via two-photon polymerization of poly(2-ethyl-2-oxazoline) diacrylates". European Polymer Journal. 122 109295. Bibcode:2020EurPJ.12209295W. doi:10.1016/j.eurpolymj.2019.109295.
  3. 1 2 Lava, Kathleen; Verbraeken, Bart; Hoogenboom, Richard (April 2015). "Poly(2-oxazoline)s and click chemistry: A versatile toolbox toward multi-functional polymers". European Polymer Journal. 65: 98–111. Bibcode:2015EurPJ..65...98L. doi:10.1016/j.eurpolymj.2015.01.014.
  4. 1 2 Černoch, Peter; Jager, Alessandro; Černochová, Zulfiya; Sincari, Vladimir; Albuquerque, Lindomar J. C.; Konefal, Rafal; Pavlova, Ewa; Giacomelli, Fernando C.; Jager, Eliezer (2021). "Engineering of pH-triggered nanoplatforms based on novel poly(2-methyl-2-oxazoline)- b -poly[2-(diisopropylamino)ethyl methacrylate] diblock copolymers with tunable morphologies for biomedical applications". Polymer Chemistry. 12 (19): 2868–2880. doi:10.1039/D1PY00141H. ISSN 1759-9954.
  5. 1 2 3 4 Viegas, Tacey X.; Bentley, Michael D.; Harris, J. Milton; Fang, Zhihao; Yoon, Kunsang; Dizman, Bekir; Weimer, Rebecca; Mero, Anna; Pasut, Gianfranco; Veronese, Francesco M. (2011-05-18). "Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery". Bioconjugate Chemistry. 22 (5): 976–986. doi:10.1021/bc200049d. ISSN 1043-1802. PMID 21452890.
  6. ↑ Hoang Thi, Thai Thanh; Pilkington, Emily H.; Nguyen, Dai Hai; Lee, Jung Seok; Park, Ki Dong; Truong, Nghia P. (2020-02-02). "The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation". Polymers. 12 (2): 298. doi:10.3390/polym12020298. ISSN 2073-4360. PMC 7077443. PMID 32024289.
  7. 1 2 3 4 5 Nemati Mahand, Saba; Aliakbarzadeh, Sanaz; Moghaddam, Armaghan; Salehi Moghaddam, Abolfazl; Kruppke, Benjamin; Nasrollahzadeh, Mahmoud; Khonakdar, Hossein Ali (September 2022). "Polyoxazoline: A review article from polymerization to smart behaviors and biomedical applications". European Polymer Journal. 178 111484. Bibcode:2022EurPJ.17811484N. doi:10.1016/j.eurpolymj.2022.111484.
  8. 1 2 Shinde, Snehal; Dargude, Shrikant; Gholap, Amol D.; Jagdale, Swati; Rajput, Amarjitsing (2026-05-20). "Poly(2-oxazoline)s: a versatile polymers shaping the future of biomedical innovations". Discover Chemistry. 3 (1) 281. doi:10.1007/s44371-026-00728-z. ISSN 3005-1193.
  9. 1 2 3 4 5 Verbraeken, Bart; Monnery, Bryn D.; Lava, Kathleen; Hoogenboom, Richard (March 2017). "The chemistry of poly(2-oxazoline)s". European Polymer Journal. 88: 451–469. Bibcode:2017EurPJ..88..451V. doi:10.1016/j.eurpolymj.2016.11.016.
  10. ↑ Viegas, Tacey X.; Fang, Zhihao; Yoon, Kunsang; Weimer, Rebecca; Dizman, Bekir (2018), "Poly(oxazolines)", Engineering of Biomaterials for Drug Delivery Systems, Elsevier, pp. 173–198, doi:10.1016/B978-0-08-101750-0.00006-4, ISBN 978-0-08-101750-0, retrieved 2026-11-03{{citation}}: CS1 maint: work parameter with ISBN (link)
  11. 1 2 3 4 5 6 7 8 9 10 de la Rosa, Victor. "Poly(2-Oxazoline)s: The Versatile Polymer Platform for Biomedicine". Sigma Aldrich. Millipore Sigma.
  12. ↑ Szwarc, M. (November 1956). "'Living' Polymers". Nature. 178 (4543): 1168–1169. Bibcode:1956Natur.178.1168S. doi:10.1038/1781168a0. ISSN 0028-0836.
  13. 1 2 3 Yang, Liuxin; Wang, Faming; Ren, Pengfei; Zhang, Tianzhu; Zhang, Qianli (May 2023). "Poly(2-oxazoline)s: synthesis and biomedical applications". Macromolecular Research. 31 (5): 413–426. doi:10.1007/s13233-023-00116-x. ISSN 1598-5032.
  14. 1 2 3 Morgese, Giulia; Benetti, Edmondo M. (March 2017). "Polyoxazoline biointerfaces by surface grafting". European Polymer Journal. 88: 470–485. Bibcode:2017EurPJ..88..470M. doi:10.1016/j.eurpolymj.2016.11.003.
  15. ↑ Armstrong, Jonathan K.; Hempel, Georg; Koling, Susanne; Chan, Linda S.; Fisher, Timothy; Meiselman, Herbert J.; Garratty, George (2007). "Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients". Cancer. 110 (1): 103–111. doi:10.1002/cncr.22739. ISSN 1097-0142. PMID 17516438.
  16. 1 2 Tagami, Tatsuaki; Nakamura, Kazuya; Shimizu, Taro; Yamazaki, Naoshi; Ishida, Tatsuhiro; Kiwada, Hiroshi (March 2010). "CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes". Journal of Controlled Release. 142 (2): 160–166. doi:10.1016/j.jconrel.2009.10.017. ISSN 0168-3659. PMID 19850094.
  17. 1 2 Sedlacek, Ondrej; de la Rosa, Victor R.; Hoogenboom, Richard (November 2019). "Poly(2-oxazoline)-protein conjugates". European Polymer Journal. 120 109246. Bibcode:2019EurPJ.12009246S. doi:10.1016/j.eurpolymj.2019.109246.
  18. ↑ Arsenie, Laura Vasilica; Lapinte, Vincent (January 2024). "A recent state of art on polyoxazoline-containing antifouling coatings for biological and environmental applications". Progress in Organic Coatings. 186 107993. doi:10.1016/j.porgcoat.2023.107993.
  19. ↑ Giardi, Chloé; Lapinte, Vincent; Charnay, Clarence; Robin, Jean Jacques (September 2009). "Nonionic polyoxazoline surfactants based on renewable source: Synthesis, surface and bulk properties". Reactive and Functional Polymers. 69 (9): 643–649. Bibcode:2009RFPol..69..643G. doi:10.1016/j.reactfunctpolym.2009.04.008.
  20. ↑ Bu, Leran; Zhang, Hena; Xu, Kang; Du, Baixiang; Zhu, Caihong; Li, Yuling (2019-01-01). "pH and reduction dual-responsive micelles based on novel polyurethanes with detachable poly(2-ethyl-2-oxazoline) shell for controlled release of doxorubicin". Drug Delivery. 26 (1): 300–308. doi:10.1080/10717544.2019.1580323. ISSN 1071-7544. PMC 6442156. PMID 30895837.
  21. 1 2 Pizzi, David; Humphries, James; Morrow, Joshua P.; Fletcher, Nicholas L.; Bell, Craig A.; Thurecht, Kristofer J.; Kempe, Kristian (December 2019). "Poly(2-oxazoline) macromonomers as building blocks for functional and biocompatible polymer architectures". European Polymer Journal. 121 109258. Bibcode:2019EurPJ.12109258P. doi:10.1016/j.eurpolymj.2019.109258.
  22. ↑ Platen, Mitja; Mathieu, Evelien; Lück, Steffen; Schubel, René; Jordan, Rainer; Pautot, Sophie (2015-05-11). "Poly(2-oxazoline)-Based Microgel Particles for Neuronal Cell Culture". Biomacromolecules. 16 (5): 1516–1524. doi:10.1021/bm501879h. ISSN 1525-7797. PMID 25807137.
  23. ↑ Mero, Anna; Pasut, Gianfranco; Via, Lisa Dalla; Fijten, Martin W.M.; Schubert, Ulrich S.; Hoogenboom, Richard; Veronese, Francesco M. (January 2008). "Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates?". Journal of Controlled Release. 125 (2): 87–95. doi:10.1016/j.jconrel.2007.10.010. ISSN 0168-3659. PMID 18031860.